Thomas Schlieve, DDS
Oral and Maxillofacial Surgery · Dallas, TXNPI 1215101209
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $12,095 of the $20,086 with a category attached, or 60.2%. Kls-martin L.p. accounts for 88.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $14,140 and has fallen 88.2% since, to $1,663 in 2025. Among oral and maxillofacial surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $242.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kls-martin L.p.$18K
- Axogen$1K
- Integra Lifesciences Corporation$431
- Nobel Biocare USA$157
- Zimmer Biomet$128
- Johnson & Johnson$120
- plus $236 from 5 others
What the payments were for
- Travel & lodging$1,3117%
- Food & beverage$6,68033%
- Gifts$12,09560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kls-martin L.p. | 46 | $17,756 |
| Axogen | 16 | $1,257 |
| Integra Lifesciences Corporation | 5 | $431 |
| Nobel Biocare USA | 6 | $157 |
| Zimmer Biomet | 2 | $128 |
| Johnson & Johnson | 1 | $120 |
| Stryker | 2 | $95 |
| Geistlich Pharma, North America, Inc. | 1 | $69 |
| Pylant Medical | 2 | $40 |
| Merck | 1 | $19 |
| Osteomed LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,086 in reported general payments places this provider in the 95th percentile of 591 oral and maxillofacial surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 188 | $5,571 |
| Pentoxifylline | 100 | $2,291 |
| Chlorhexidine Gluconate | 355 | $1,657 |
| Dexamethasone | 27 | $1,179 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 57 | $699 |
| Doxycycline Monohydrate | 37 | $692 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $398 |
| Ibuprofen | 41 | $165 |
| Amoxicillin | 65 | $120 |
| Oxycodone Hcl | 25 | $116 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Dallas
- John ZunigaDallas$61K
- Randy SanovichDallas$32K
- Likith ReddyDallas$11K
- Patrick WongDallas$11K
- Andrew Read-FullerDallas$7K
- John WallaceDallas$7K
- James MelvilleHouston$239K
- Pedro FrancoIrving$91K
- Fayette WilliamsFort Worth$74K
- Craig BuchmannKeller$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.